BR1: A new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles

Investigative Radiology

Volumn 30, Issue 8, 1995, Pages 451-457

  Schneider, Michel ^a   Arditi, Marcel ^a   Barrau, Marie Bernadette ^a   Brochot, Jean ^a   Broillet, Anne ^a   Ventrone, Roger ^a   Yan, Feng ^a  

^a Bracco Suisse SA   (Switzerland)

Author keywords

Left heart opacification; Sulfur hexafluoride (SF6) bubbles; Transpulmonary bubbles; Ultrasound contrast agent

Indexed keywords

BR 1; CONTRAST MEDIUM; SODIUM CHLORIDE; SULFUR HEXAFLUORIDE; UNCLASSIFIED DRUG;

ACOUSTICS; ANIMAL EXPERIMENT; ARTICLE; DIAGNOSTIC VALUE; DIASTOLE; DRUG FORMULATION; ECHOGRAPHY; HEART LEFT VENTRICLE; IMAGING; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SWINE; SYSTOLE;

EID: 0029116608     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/00004424-199508000-00001     Document Type: Article

References (14)

1. Schlicf R, Schürmann R, BalzcrT, Zomack M, NiendorfHP. Saccharide based contrast agents. In: Nanda NC, Schlicf R, cds. Advances in echo imaging using contrast enhancement. Dordrecht, Netherlands: Kluwer; 1993:71–96.
2. Christiansen C, Kryvi H, Sontum PC, Skotland T. Physical and biochemical characterization of Albunex, a new ultrasound contrast agent consisting of air-lilled albumin microspheres suspended in a solution of human albumin. Biotcchnol Appl Bio-chem 1994;19:307–320.
3. Unger EC, Lund PJ, Slten D-K, Fritz T, Ycllowhair D, New TE. Nitrogen-filled liposomes as a vascular US contrast agent: Preliminary evaluation. Radiology 1992; 185:453–456.
4. Schneider M, Bussat P, Barrau M-B, Arditi M, Yan F, Hybl E. Polymeric microballoons as ultrasound contrast agents: Physical and ultrasonic properties compared with sonicated albumin. Invest Radiol 1992;27:134–139.
5. Schneider M, Yan F, Grenier P, Puginicr J, Barrau MB. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-lilled microvesiclcsand methods for the preparation thereof. US Patent 5’413774. Priority Jan 23, 1992.
6. Mattrey RF, Steinbach GC, Peterson T, Hall LA. Echogcnic enhancement of the perfused myocardium following the intravenous administration of PFC microbubbles. Radiology 1994; 193(suppl):367.
7. Unger EC, Tucson AZ, Barrette TL, et al. MRX-115: Pcrfluoro-propanc gas-lilled lipid bilayers as an ultrastablc US perfusion contrast agent. Radiology 1994; I93(suppl):366.
8. Beppu S, Matsuda H, Shishido T, Miyatake K. Success of myocardial contrast echocardiography by peripheral venous injection method: Visualization of area at risk. Circulation 1993; 88:1–401.
9. Sigelmann RA, Reid JM. Analysis and measurement of ultrasound backscattering from an ensemble of scatterers excited by sine-wave bursts. J Acoust Soc Am 1973; 53:1351–1355.
10. Fei DY, Shung K.K. Ultrasonic backscatter from mammalian tissues. J Acoust Soc Am 1985;78:871–876.
11. Geny B, Mettauer B, Muan B, et al. Safety and efficacy of a new transpulmonary echo contrast agent in echocardio-graphic studies in patients. J Am Coll Cardiol 1993;22: 1193–1198.
12. Völler H, Schröder K, Spielberg C, et al. Does cardiac function modify left heart opacification with transpulmonary echo contrast agents? Echocardiography 1993;10:41–47.
13. Iliceto S, Caiati C, Aragona P, Verde R, Schlief R, Rizzon P. Improved doppler signal intensity in coronary arteries after intravenous peripheral injection of a lung-crossing contrast agent (SHU 508). J Am Coll Cardiol 1994;23:184–190.
14. Fritzsch T, Hilmann J, Kämpfe M, Müller N, Schöbel C, Siegert J. SHU 508: A transpulmonary echocontrast agent: Initial experience. Invest Radiol 1990;25(suppl):S160—S161.